Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059518) titled 'Elucidation of the pathophysiology of various renal and urinary tract diseases through immunohistochemical analysis of exfoliated cells in urine' on Nov. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Niigata University of Health and Welfar
Condition:
Condition - Fabry disease and renal and urological diseases
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Non-invasive immunohistochemical analysis of exfoliated urinary cells enables early diagnosis and treatment of renal and urological diseases, thereby helping to reduce healthcare costs.
Basic objectives2 - Bio-availability
Eligibility:
Age-lower limit - 2
years-old
Gender - Male and Female
Key inclusion criteria - Patients who were suspected of having glomerulonephritis, diabetic nephropathy, or malignant tumors of the renal or urinary tract during outpatient visits at collaborating or partner research institutions, and who provided informed consent to participate in the study.
Key exclusion criteria - Patients whose remaining sample volume is insufficient for the measurements required in this study, or who are otherwise deemed unsuitable for participation by the principal investigator.
Target Size - 200
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 10 Month 21 Day
Date of IRB - 2025 Year 10 Month 23 Day
Anticipated trial start date - 2025 Year 10 Month 24 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067876
Disclaimer: Curated by HT Syndication.
